Hyperfine, Inc.

HYPR ·Healthcare, Medical Devices, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $35.1M $37.6M $75.2M $117.5M $188.5M $62.7M $26.4M
Accounts Receivable $5.3M $6.0M $3.2M $2.1M $553.0K $174.0K
Inventory $7.1M $5.8M $6.6M $4.6M $4.3M $1.7M
Total Current Assets $50.9M $53.7M $88.9M $128.7M $197.5M $68.3M
Property, Plant & Equipment $2.5M $3.1M $3.0M $3.2M $3.8M $1.9M
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $55.3M $58.9M $94.2M $134.1M $202.5M $71.5M
Liabilities
Accounts Payable $4.1M $1.6M $1.2M $678.0K $2.2M $948.0K
Total Current Liabilities $11.7M $8.7M $8.8M $8.8M $15.7M $4.1M
Long-Term Debt
Total Liabilities $14.3M $9.9M $9.8M $10.3M $16.2M $4.3M
Stockholders' Equity
Retained Earnings $-330.0M $-294.4M $-253.7M $-209.5M $-136.3M $-71.5M
Total Stockholders' Equity $41.0M $49.0M $84.4M $123.7M $186.2M $-61.1M $-39.9M
Warren Buffett

What the wise do in the beginning, fools do in the end.